Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Kevin Tan

Kevin Tan is recorded as CFO and Chief Accounting Officer at Solid Biosciences Inc. (SLDB). Solid Biosciences Inc. reported in an 8-K filed January 9, 2023 that Kevin Tan was appointed principal accounting officer, effective January 9, 2023. Solid Biosciences Inc. reported in an 8-K filed January 9, 2023 that Kevin Tan was appointed Chief Financial Officer, effective January 9, 2023. The proxy statement of Solid Biosciences Inc. reports total compensation of $1,346,305 for Kevin Tan in fiscal 2023, including a base salary of $416,146.

“In connection with his appointment, Mr. Tan will serve as the Company's principal financial officer and principal accounting officer.”
Solid Biosciences Inc. Form 8-K, filed January 9, 2023 · Read the filing
“On January 6, 2023, the Company's Board of Directors (the "Board") appointed Kevin Tan as the Company's Chief Financial Officer, effective as of January 9, 2023 (the "Appointment Date").”
Solid Biosciences Inc. Form 8-K, filed January 9, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Solid Biosciences Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Solid Biosciences Inc. (SLDB) $416,146 $1,346,305

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.